Selma Kanazir Selected Research

sulfinosine

1/2006	The combination of sulfinosine and 8-Cl-cAMP induces synergistic cell growth inhibition of the human neuroblastoma cell line in vitro.
8/2002	Sulfinosine-induced cell growth inhibition and apoptosis in human lung carcinomas in vitro.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Selma Kanazir Research Topics

Disease

7	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 04/2014
4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 09/2007
3	Gliosis 01/2020 - 05/2003
3	Neoplasms (Cancer) 05/2003 - 01/2002
2	Brain Injuries (Brain Injury) 03/2022 - 08/2010
2	Frailty 01/2021 - 01/2020
2	Inflammation (Inflammations) 01/2019 - 01/2018
2	Parkinson Disease (Parkinson's Disease) 02/2018 - 06/2005
2	Osteosarcoma (Osteogenic Sarcoma) 01/2018 - 09/2017
2	Cognitive Dysfunction 08/2017 - 10/2016
2	Glioma (Gliomas) 05/2003 - 01/2002
1	Traumatic Brain Injuries (Traumatic Brain Injury) 03/2022
1	Body Weight (Weight, Body) 01/2021
1	Proteostasis Deficiencies 01/2021
1	Sleep Wake Disorders 02/2018
1	Hypokinesia (Bradykinesia) 02/2018
1	Movement Disorders (Movement Disorder) 02/2018
1	Substance-Related Disorders (Drug Abuse) 09/2017
1	Multiple Sclerosis 01/2017
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2017
1	Demyelinating Diseases (Demyelinating Disease) 01/2017
1	Encephalitis (Encephalitis, Rasmussen) 10/2016
1	Neuroinflammatory Diseases 10/2016
1	Psychotic Disorders (Schizoaffective Disorder) 12/2015
1	Primary Ovarian Insufficiency 05/2013
1	Neuroblastoma 01/2006
1	Brain Neoplasms (Brain Tumor) 05/2003
1	Lung Neoplasms (Lung Cancer) 08/2002
1	Carcinoma (Carcinomatosis) 08/2002
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 08/2002
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2002

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2021 - 06/2005
4	Amyloid (Amyloid Fibrils)IBA 01/2020 - 04/2014
3	Anesthetics (Anesthetic Agents)IBA 08/2017 - 12/2015
3	CholesterolIBA 01/2017 - 08/2010
2	CorticosteroneIBA 01/2021 - 11/2009
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 11/2009
2	Fish OilsIBA 01/2019 - 09/2018
2	Propofol (Diprivan)FDA LinkGeneric 09/2017 - 10/2016
2	Pharmaceutical PreparationsIBA 09/2017 - 12/2015
2	Cholesterol 24-Hydroxylase (CYP46A1)IBA 01/2017 - 08/2010
2	CytokinesIBA 10/2016 - 09/2015
2	8-chloro-cyclic adenosine monophosphateIBA 01/2006 - 01/2002
2	sulfinosineIBA 01/2006 - 08/2002
2	purineIBA 01/2006 - 08/2002
1	GlucocorticoidsIBA 03/2022
1	Neuroprotective AgentsIBA 03/2022
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2021
1	Amyloid beta-PeptidesIBA 01/2021
1	UbiquitinIBA 01/2021
1	Dextroamphetamine (Dexedrine)FDA LinkGeneric 01/2021
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2021
1	Phospholipids (Phosphatides)FDA LinkGeneric 09/2018
1	Biomarkers (Surrogate Marker)IBA 02/2018
1	Cholinergic Agents (Cholinergics)IBA 02/2018
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	Indicators and Reagents (Reagents)IBA 01/2018
1	Interleukin-17 (Interleukin 17)IBA 01/2018
1	Dopamine Receptors (Dopamine Receptor)IBA 09/2017
1	Sodium Glutamate (Accent)IBA 09/2017
1	Threonine (L-Threonine)FDA Link 09/2017
1	Calcium-Calmodulin-Dependent Protein KinasesIBA 09/2017
1	Dopamine and cAMP-Regulated Phosphoprotein 32IBA 09/2017
1	ApolipoproteinsIBA 01/2017
1	Apolipoproteins E (ApoE)IBA 01/2017
1	LipidsIBA 01/2017
1	Oxidoreductases (Dehydrogenase)IBA 01/2017
1	Messenger RNA (mRNA)IBA 01/2017
1	Fas Ligand Protein (Fas Ligand)IBA 10/2016
1	Death Domain ReceptorsIBA 10/2016
1	CathepsinsIBA 01/2016
1	Peptide Hydrolases (Proteases)FDA Link 01/2016
1	Cysteine (L-Cysteine)FDA Link 01/2016
1	Matrix Metalloproteinases (MMPs)IBA 09/2015
1	ChemokinesIBA 09/2015
1	Presenilin-1IBA 04/2014
1	Collagen Type I (Type I Collagen)IBA 05/2013
1	Cytochrome P450 Family 46 (CYP46)IBA 08/2010
1	GAP-43 Protein (GAP 43 Protein)IBA 11/2009
1	alpha-SynucleinIBA 09/2007
1	SynaptophysinIBA 06/2005
1	Oxidopamine (6 Hydroxydopamine)IBA 06/2005
1	AntigensIBA 05/2003
1	Antineoplastic Agents (Antineoplastics)IBA 08/2002
1	Adenosine (Adenocard)FDA LinkGeneric 01/2002
1	Cyclin B1IBA 01/2002

Therapy/Procedure

3	Therapeutics 01/2020 - 08/2002
2	Diet Therapy (Therapy, Diet) 04/2014 - 09/2007
1	Anesthesia 09/2017